Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Jiaoda Onlly CoSHSE:600530 -3.92%39 Days Payable is 31.15 as of Mar. 2026, which is 48% below its 10-year median of 59.57. GuruFocus rates SHSE:600530 with a GF Score™ of 39/100 and a GF Value™ of ¥2.95 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 925 Drug Manufacturers companies, Shanghai Jiaoda Onlly Co ranks worse than 89.3% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Jiaoda Onlly Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Jiaoda Onlly Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Jiaoda Onlly Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shanghai Jiaoda Onlly Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Shanghai Jiaoda Onlly Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Jiaoda Onlly Co (SHSE:600530) has a Days Payable of 31.15 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Jiaoda Onlly Co and its competitors. This is 48% below median its historical median of 59.57. Over the past decade, Shanghai Jiaoda Onlly Co's Days Payable has ranged from 30.21 to 79.49. According to the industry distribution chart, Shanghai Jiaoda Onlly Co ranks #826 out of 925 companies in the Drug Manufacturers industry, placing it in the top 89.3%.
Is Shanghai Jiaoda Onlly Co's Days Payable too high?
Shanghai Jiaoda Onlly Co's current Days Payable of 31.15 is 48% below median its 10-year median of 59.57. Over the past 10 years, this metric has ranged from a low of 30.21 to a high of 79.49. The Drug Manufacturers industry median Days Payable is 90.38. Shanghai Jiaoda Onlly Co's value of 31.15 is 65.5% below this industry median. Based on the distribution chart, Shanghai Jiaoda Onlly Co ranks #826 out of 925 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Shanghai Jiaoda Onlly Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Jiaoda Onlly Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Shanghai Jiaoda Onlly Co ranks #826 out of 925 companies for Days Payable. This places Shanghai Jiaoda Onlly Co in the lower half of its industry. The industry median Days Payable is 90.38. Shanghai Jiaoda Onlly Co's value of 31.15 is 65.5% below this benchmark. Historically, Shanghai Jiaoda Onlly Co's own Days Payable has ranged from 30.21 to 79.49 over the past decade. While the company's 10-year median is 59.57 vs. the industry median of 90.38, Shanghai Jiaoda Onlly Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Jiaoda Onlly Co's current Days Payable of 31.15 is 65.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Jiaoda Onlly Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Jiaoda Onlly Co's current Days Payable is 31.15, which is 48% below median its own 10-year median of 59.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Jiaoda Onlly Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co (SHSE:600530) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.95, compared to a current price of ¥4.66 — trading 58% above its estimated fair value. The current Days Payable is 31.15, which is 48% below median its 10-year median of 59.57 and 65.5% below the Drug Manufacturers industry median of 90.38. Shanghai Jiaoda Onlly Co's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai Jiaoda Onlly Co (SHSE:600530), the current Days Payable is 31.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Jiaoda Onlly Co (SHSE:600530) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Jiaoda Onlly Co stock appears to be overvalued.
The current stock price of ¥4.66 is trading 58% above its estimated GF Value™ of ¥2.95.
GuruFocus considers Shanghai Jiaoda Onlly Co to be Significantly Overvalued.
Key valuation signals for SHSE:600530:
Days Payable: 31.15 (48% below median its 10-year median of 59.57)
GF Value™: ¥2.95 vs. price of ¥4.66 (58% above fair value)
Industry Position: 65.5% below the Drug Manufacturers median (#826 of 925)
No single metric tells the full story. See the SHSE:600530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Jiaoda Onlly Co Ltd is engaged in producing and distributing healthcare products. The company is also involved in real estate and financial investment. Its main products are biological products and healthcare products.
39GF Score
Get the complete analysis for SHSE:600530
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600530 has been successfully added to your 
